With few exceptions, almost all bacteria require iron for growth and survival (27) . Iron acquisition in nature is complicated, however, due to the low solubility of iron under aerobic conditions at neutral pH (27) . Pathogenic organisms face similar restrictions in human hosts, since iron is generally sequestered intracellularly in heme-containing compounds, or in fluids, by iron-binding proteins such as lactoferrin and transferrin (39) . Many bacteria overcome this problem by synthesizing high-affinity iron chelators called siderophores (29) . Together with siderophore-specific outer membrane receptors, these facilitate the uptake of iron required to sustain growth and pathogenesis (28) .
Pseudomonas aeruginosa, an opportunistic human pathogen (10), produces two known siderophores, pyoverdine (6) and pyochelin (5) , in response to iron limitation. Pyoverdine is the superior chelator, at least at neutral pH (23) , and is required for in vivo growth and virulence (24, 34, 48) . Genes involved in the biosynthesis of pyoverdine localize in two gene clusters, the pvc operon (45, 46) and the pvd locus (22, 26, 36, 50) , which are implicated in the synthesis of the chromophore and peptide moieties, respectively. The fpvA gene encoding the ferric pyoverdine receptor is also localized in the pvd cluster (22, 35, 36) .
Although it is an essential nutrient for growth and pathogenesis, iron, in excess, is toxic to cells (12) . Thus, uptake genes are tightly regulated by intracellular iron levels, mediated by the Fur repressor (8, 13, 38) . Though a Fur homologue has been identified in P. aeruginosa (38) , it does not directly regulate genes involved in pyoverdine biosynthesis. Rather, an alternative sigma factor, PvdS (7, 21, 26, 51) , which positively regulates the expression of several pyoverdine biosynthetic genes (20, 52) , is itself regulated by Fur (7, 20, 26) . Pyoverdine control of FpvA expression has also been reported (11, 35) , reminiscent of siderophore-dependent receptor gene expression in Escherichia coli (14) and Pseudomonas putida (17) . In E. coli, ferric dicitrate upregulates its receptor, FecA, and, via a two-component system, FecIR (49) , which is responsive to FecA binding of its cognate siderophore (4, 49) . Similarly, pseudobactin BN7/8 stimulates expression of its receptor, PupB, via FecIR homologues, dubbed PupIR (17) . FecI is an extracytoplasmic-function (ECF) sigma factor (1) whose activity is controlled by FecR (30) . Recently, a third example of this type of regulatory system was reported in Bordetella bronchiseptica, where bupIR gene products were shown to control expression of a putative siderophore receptor, BfrZ (37) . In an effort to understand the basis of pyoverdine control of FpvA production in P. aeruginosa, then, FecIR homologues were sought in the pvd locus of the available PAO genome (http: //www.pseudomonas.com) (47) .
MATERIALS AND METHODS
Bacterial strains and growth media. Bacterial strains and plasmids used in this study are listed in Table 1 . Routine growth for both P. aeruginosa and E. coli was performed in Luria-Bertani (LB) medium (Luria broth base; Difco). Growth under iron-limited conditions was performed by using iron-free BM2 succinate or glucose medium (35) , which was made to be iron sufficient, as necessary, through the addition of 100 M FeSO 4 . Antibiotic selections used for P. aeruginosa included tetracycline (70 g/ml in LB and 30 g/ml in BM2 succinate), chloramphenicol (200 g/ml in LB and 30 g/ml in BM2 succinate) and kanamycin (for ⌬aphA strains only, 100 g/ml in LB). For E. coli, tetracycline was used at 10 g/ml (in LB) or 5 g/ml (in BM2 glucose), chloramphenicol was used at 50 g/ml (in LB) or 20 g/ml (in BM2 glucose), and kanamycin was used at 50 g/ml.
DNA techniques. Basic DNA procedures, including restriction endonuclease digestions, ligations, transformations, and agarose gel electrophoresis, were performed as described previously (24) . Plasmid DNA isolation was performed by using the alkaline lysis method (24) or by using a plasmid Midi kit (Qiagen, Mississauga, Ontario, Canada). Genomic DNA was extracted from P. aeruginosa by using the method of Barcak et al. (3) . DNA fragments for use in cloning were extracted from agarose gels by using Prep-A-Gene (Bio-Rad Labs, Richmond, Calif.) in accordance with the manufacturer's instructions. Nucleotide sequencing of plasmid-borne DNA was carried out by Cortec DNA Services, Inc. (Kingston, Ontario, Canada). Nucleotide sequence alignments were performed using the GENESTREAM website (http://xylian.igh.cnrs.fr/bin/align-guess.cgi) (33) .
Cloning of fpvI and construction of a ⌬fpvI mutant. The fpvI gene was amplified by PCR by utilizing primers pff (5Ј-CATGGAATTCTGGTAGTTGGAAG GAATCCAGC-3Ј; the EcoRI site is underlined) and pfr (5Ј-AGCTGAATTCC AGTTGCCTGAGTCAATTCCAG-3Ј; the EcoRI site is underlined). The PCR mixture contained 50 ng of P. aeruginosa chromosomal DNA, 30 pmol of each primer, 0.2 mM (each) deoxynucleoside triphosphate, 1 mM MgSO 4 , and 3% (vol/vol) dimethyl sulfoxide in 1ϫ ThermoPol buffer (New England Biolabs, Mississauga, Ontario, Canada), which was heated for 3 min at 95°C before the addition of 2 U of VentR DNA polymerase (New England Biolabs). The reaction was processed for 30 cycles of 1 min at 95°C, 20 s at 58°C, and 1 min at 72°C, followed by 10 min at 72°C. The resulting amplicon was purified by a Qiaquick PCR purification kit (Qiagen), digested with EcoRI, and cloned into EcoRIdigested pRK415, to yield pAR001. Nucleotide sequencing confirmed that the fpvI gene was cloned in the same orientation as the lac promoter.
To construct ⌬fpvI mutants of P. aeruginosa, an internal deletion of the fpvI gene was first constructed in the gene replacement vector pK18mobsacB. This was accomplished by amplifying PCR products (by using the conditions and parameters described above) corresponding to sequence upstream and downstream of the deletion end points in fpvI by using primer pairs pflaeco (5Ј-GA TCGAATTCATGCTGCCTCTCGCGATGTC-3Ј; the EcoRI site is underlined) and pflakpn (5Ј-CGTAGGTACCGGCACTGAGGAATCGCAG-CA-3Ј; the KpnI site is underlined) and pfrakpn (5Ј-CGTAGGTACCAACGCGATGAAG CACTGTC-3Ј; the KpnI site is underlined) and pfrahind (5Ј-GACTAAGCTTG TGTTCCAGGTACTGGCTCTG-3Ј; the HindIII site is underlined), respectively. The downstream fragment was purified by using a Qiaquick PCR purification kit (Qiagen), digested with KpnI and HindIII, and cloned into KpnIHindIII-restricted pEX18Tc. The resulting vector was then digested with EcoRI and KpnI, and the EcoRI-KpnI-digested upstream fragment was cloned into this vector, yielding the ⌬fpvI plasmid pAR002. The ⌬fpvI gene was excised from pAR002 by digestion with EcoRI and XmnI, and the resultant 1.8-kb fragment was cloned into EcoRI-XmnI-restricted pK18mobsacB to yield pAR003. This vector was then transformed into E. coli S17-1 and mobilized into P. aeruginosa strains K1120 and K1203 by using a previously described protocol (45) . By using chloramphenicol (5 g/ml) as a counterselective agent, kanamycin-resistant transconjugants were recovered and subsequently streaked onto LB agar containing 10% (wt/vol) sucrose. Sucrose-resistant colonies arising after 24 h of growth at 37°C were screened for the presence of a ⌬fpvI chromosomal deletion by colony PCR (42) with primers pff and pfr by using the conditions described above.
Whole-cell extracts. Whole-cell protein extracts were prepared from cultures of P. aeruginosa grown overnight in iron-sufficient or iron-deficient BM2 succinate medium following subculture (1:99 dilution) into the same medium and growth to an optical density at 600 nm (OD 600 ) of approximately 0.7. Two 1.5-ml aliquots were centrifuged sequentially in the same microcentrifuge tube at 13,000 rpm (Biofuge pico; Heraeus Instruments) and resuspended in 400 l of phosphate-buffered saline (1.7 mM NaH 2 PO 4 SDS-polyacrylamide gel electrophoresis and immunoblotting. Whole-cell extract samples were electrophoresed on 10% (wt/vol) SDS-polyacrylamide gels (53) and electrotransferred onto Immobilon-P polyvinylidene difluoride membranes (Millipore) as described previously (54) . Equal loading of protein in all wells was confirmed by rapid Coomassie staining of duplicate gels (9) . Membranes were probed with a polyclonal anti-FpvA antibody as described previously (36) .
␤-Galactosidase assay. P. aeruginosa strains containing promoter-lacZ fusions were grown in iron-limited BM2 succinate medium supplemented with the appropriate antibiotics for approximately 18 h at 37°C. In some experiments, pyoverdine was included at 100 g/ml. Cultures were then diluted 1:49 into the same medium without antibiotics and grown at 37°C to an OD 600 of ϳ0.7 before being assayed for ␤-galactosidase activity as described previously (25) . To assess the impact of the cloned fpvI gene on fpvA-lacZ expression in a heterologous host, E. coli DH5␣ harboring pEJB3 and either pAR001 (which carries fpvI) or pAR005 (vector control) was grown in iron-limited BM2 glucose minimal medium with the appropriate antibiotics to an OD 600 of ϳ0.5 before being assayed for ␤-galactosidase activity.
RNA isolation and RT-PCR. RNA was isolated by using the RNeasy RNA isolation kit (Qiagen) in accordance with the manufacturer's instructions. Samples were then treated with RQ1 DNase (Promega, Madison, Wis.) in accordance with the manufacturer's instructions, and RNA was quantitated by spectrophotometry. Reverse transcription (RT)-PCR was carried out by using intragenic primers specific for fpvI (namely, piff [5Ј-ACTGGAATTCCAGCGA GCAGGAGTCGTCTT-3Ј] and pifr [5Ј-ACTGGAATTCTTGCGCAACAGGA AGGAAC-3Ј]) and rpsL (namely, rpsL1 [5Ј-GCAACTATCAACCAGCTG-3Ј] and rpsL2 [5Ј-GCTGTGCTCTTGCAGGTTGTG-3Ј]) and the One Step RT-PCR kit (Qiagen) by following the manufacturer's instructions. PCR conditions were as described above, except that the annealing temperature was 59°C. Non-RT controls were run to ensure that no DNA contaminated the RNA samples.
RESULTS AND DISCUSSION
Role of FpvI in fpvA expression. Examination of the Pseudomonas genome (Pseudomonas genome project website, http: //www.pseudomonas.com) by using BLASTX (National Center for Biotechnology Information webpage, http://www.ncbi.nlm .nih.gov/BLAST) revealed two open reading frames, PA2387 and PA2388, whose deduced products exhibited homology to FecIR and PupIR, and they were subsequently designated fpvI and fpvR (in accordance with the nomenclature suggested by I. Lamont, University of Otago). The fpvI and fpvR genes were transcribed divergently from one another and were localized within the so-called pvd locus between the pyoverdine biosynthetic genes pvdK (19) and pvdA (50) . FpvI showed almost 30.6% identity (59% overall similarity) to FecI (accession no. AAA23766), 31.6% identity (63.3% overall similarity) to BupI (accession no. CAB71123), and 29.5% identity (60.1% overall similarity) to PupI (accession no. CAA54870). To assess its role in FpvA production, then, an in-frame fpvI deletion was constructed in P. aeruginosa strain K1120, yielding K2100. Although FpvA production increased substantially in FpvI ϩ strains under iron restriction (compare lanes 1 and 2 in Fig.  1A) , loss of fpvI in K2100 abolished this iron-limited increase in FpvA (Fig. 1A, lane 3) . FpvA production in iron-limited K2100 was, however, restored by the vector-borne fpvI gene present on plasmid pAR001 (Fig. 1A, lane 4) , confirming a role for this probable ECF sigma factor in FpvA expression under iron-limiting conditions. To assess whether FpvI was influencing FpvA at the level of gene expression, an fpvA-lacZ fusion vector, pEJB3, was introduced into FpvI ϩ and FpvI Ϫ P. aeruginosa, and ␤-galactosidase activity was determined for cells cultured under iron-limiting conditions. As seen in Table 2 , loss of fpvI in K2100 reduces fpvA expression approximately fivefold relative to that of the FpvI ϩ parental strain, K1120. Moreover, the cloned fpvI gene restored fpvA expression to wild-type levels in K2100 and stimulated the expression of the fpvA-lacZ fusion in E. coli (Table 2 ). In contrast, pvdD-lacZ expression, previously demonstrated to be dependent on the PvdS ECF sigma factor (21), was not stimulated by FpvI in E. coli (data not shown). These data are consistent with FpvI directly and positively promoting fpvA gene expression.
Iron regulation of fpvI. Since many iron uptake and regulatory genes, including that encoding the aforementioned PvdS ECF sigma factor, are themselves regulated by iron, with regulation mediated by the Fur repressor protein, it was of interest to assess regulation of fpvI by iron. By RT-PCR, expression of fpvI was clearly shown to increase under conditions of iron limitation (Fig. 2) . Moreover, examination of the nucleotide sequence upstream of fpvI revealed the presence of a putative Fur box (Fig. 3, underlined) , with 12 of 19 nucleotides matching the consensus Fur box sequence; indeed, Fur binding to this site has been previously confirmed (fpvI was previously identified as a Fur-regulated gene dubbed pig32 [31] ). Thus, the observation that expression of fpvA is governed by an iron-regulated probable sigma factor explains the known iron regulation of this receptor gene despite the absence of a Fur box upstream of the fpvA gene. This indirect iron regulation of gene expression is reminiscent of the iron-regulated expression of the pyoverdine biosynthetic (pvd) genes, which also lack Fur boxes and whose expression is governed by the iron-regulated ECF sigma factor PvdS (20, 21, 32, 52) .
Involvement of pyoverdine in FpvI-mediated fpvA expression. In order to ascertain whether FpvI mediates the positive influence of pyoverdine on FpvA production, an fpvI deletion was created in a pyoverdine-deficient derivative of P. aeruginosa, K1203, and the ability of exogenously added pyoverdine to promote FpvA production in the resulting strain, K2102, was assessed. Immunoblotting with an anti-FpvA antibody confirmed previous findings that FpvA production was reduced in a pyoverdine-deficient (but FpvI ϩ ) strain (Fig. 1B , lane 2; compare with lane 1) and can be restored by the addition of exogenous pyoverdine (Fig. 1B, lane 3) . In contrast, pyoverdine did not restore FpvA production in the FpvI Ϫ strain K2102 (Fig. 1B, lane 5 ; compare with lane 4). Introduction of the cloned fpvI gene on plasmid pAR001 did, however, restore pyoverdine stimulation of FpvA production in this mutant (Fig. 1B, lane 6) . Again, this effect occurred at the level of fpvA gene expression, with pyoverdine enhancing expression of the fpvA-lacZ fusion in the FpvI ϩ strain, K1203, but not in the FpvI Ϫ strain, K2102 ( Table 2 ). The observation that FpvI mediates the positive influence of pyoverdine on fpvA gene expression is reminiscent of PvdS and its mediation of the positive influence of this siderophore on pvd gene expression, the latter in a process involving the receptor itself and an antisigma factor, FpvR (18, 41) . Pyoverdine-dependent FpvI-mediated stimulation of fpvA expression appears also to be controlled by FpvA and FpvR (I. L. Lamont, personal communication).
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